Arteriotomy Closure Devices Market Report 2026

Arteriotomy Closure Devices Market Overview

• Arteriotomy Closure Devices market size has reached to $1.72 billion in 2025 • Expected to grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Rising Cardiovascular Disease Prevalence Fuels Market Growth • Market Trend: The Growing Demand For Minimally Invasive Vascular Access Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Arteriotomy Closure Devices Market?

An arteriotomy closure device (ACD) is a medical device designed to seal the puncture site in an artery following procedures such as catheterization or angiography. It facilitates hemostasis by closing the arterial opening, reducing bleeding risks, and promoting faster recovery compared to manual compression methods. ACDs are commonly used in minimally invasive vascular procedures to enhance patient safety and procedural efficiency. The main product types of arteriotomy closure devices are active closure devices and passive closure devices. Active closure devices are medical devices used to seal arterial puncture sites after procedures, utilizing mechanical or mechanical-hemostatic methods to achieve hemostasis and facilitate faster recovery. It is utilized in various applications, including femoral and radial arterial access procedures, and serves a wide range of end users, such as hospitals, ambulatory care centers, and other healthcare facilities.

What Is The Arteriotomy Closure Devices Market Growth Forecast?

The arteriotomy closure devices market size is expected to see strong growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for next-generation vascular closure solutions, rising focus on reducing procedure-related complications, expansion of outpatient vascular procedures, growing investments in bioresorbable materials, increasing adoption of advanced closure technologies. Major trends in the forecast period include increasing adoption of suture-based closure devices, rising preference for radial access closure solutions, growing use of bioabsorbable hemostatic materials, expansion of minimally invasive vascular procedures, enhanced focus on faster patient recovery.

Global Arteriotomy Closure Devices Market Segmentation

1) By Product: Active Closure Devices, Passive Closure Devices 2) By Application: Femoral Arterial Access Procedures, Radial Arterial Access Procedures 3) By End User: Hospitals, Ambulatory Care Centers, Other End Users Subsegments: 1) By Active Closure Devices: Suture-Based Devices, Staple-Based Devices, Vascular Closure Devices With Collagen Or Hemostatic Agents, Balloon-Based Devices 2) By Passive Closure Devices: Compression Devices, Hemostatic Patches Or Sponges, Vascular Plugs Or Plugs

What Is The Driver Of The Arteriotomy Closure Devices Market?

The increase in the prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the arteriotomy closure devices market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders that affect the heart and blood vessels. The increase in the prevalence of cardiovascular diseases (CVDs) is largely due to rising rates of risk factors such as unhealthy diets, physical inactivity, and obesity, along with an aging population. Arteriotomy closure devices are essential in cardiovascular treatments as they quickly and securely close arterial puncture sites, reducing complications and improving recovery after procedures like angioplasties and catheterizations. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the increase in the prevalence of cardiovascular diseases (CVDs) is driving growth in the arteriotomy closure devices industry.

Key Players In The Global Arteriotomy Closure Devices Market

Major companies operating in the arteriotomy closure devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Terumo Corporation, Teleflex Incorporated, Cook Medical Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd., Haemonetics Corporation, Cordis Corporation, Asahi Intecc Co. Ltd., LeMaitre Vascular Inc., Cardiva Medical Inc., AccessClosure Inc., Vasorum Limited, Invamed (Pty) Ltd., Artio Medical Inc., SUTUREGARD Medical Inc., Vivasure Medical

Global Arteriotomy Closure Devices Market Trends and Insights

Major companies operating in the arteriotomy closure devices market are prioritizing product innovation to enhance procedural efficiency, improve patient outcomes, and meet the rising demand for minimally invasive vascular access solutions. A mid-bore venous closure device is a medical tool designed to seal venous access sites created by mid-sized catheters or sheaths, promoting hemostasis and aiding in patient recovery after interventional procedures. For instance, in June 2024, Haemonetics Corp, a US-based healthcare company, expanded its VASCADE portfolio with the launch of the VASCADE MVP XL mid-bore venous closure device. This device, tailored for larger sheaths (10-12F, up to 15F outer diameter) used in procedures like cryoablation, incorporates 58% more collagen and a larger collapsible disc to achieve rapid hemostasis. Complementing Haemonetics' existing range of small- and mid-bore vascular closure solutions, this innovation underscores the company's leadership in advanced closure technologies.

What Are Latest Mergers And Acquisitions In The Arteriotomy Closure Devices Market?

In January2025, Kalteq Group, a Greece-based medical device distributor, entered into an exclusive partnership with Teleflex. with this partnership, Kalteq Group will distribute the MANTAVascular Closure Device in Greece, expanding access to innovative large-bore femoral arterial closure solutions that improve procedural efficiency and patient outcomes. Teleflex, Inc. is a U.S.-based company that offers arteriotomy closure devices.

Regional Outlook

North America was the largest region in the arteriotomy closure devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Arteriotomy Closure Devices Market?

The arteriotomy closure devices market consists of sales of angiograms, catheterizations, and other interventional surgeries. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.